Secondary FGFR2 Mutations Drive Drug Resistance to FGFR Inhibitors in Bile Duct Cancer
The Mass General Cancer Center's Lipika Goyal, MD, MPhil and colleagues set out to explore the molecular foundations of acquired resistance.
Safe Care CommitmentGet the latest news on COVID-19, the vaccine and care at Mass General.Learn more
Treats:
Languages:
Mass General Cancer Center: Hematology Oncology
55 Fruit St.
Boston, MA 02114
Phone: 617-724-4000
Fax: 617-643-2683
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
Mass General is the #1 Research Hospital in America and recognized in 14 specialties assessed by U.S. News & World Report.
The Mass General Cancer Center's Lipika Goyal, MD, MPhil and colleagues set out to explore the molecular foundations of acquired resistance.